Åsa Segerstolpe holds a Ph.D. degree from Stockholm University, Sweden, focusing on ribosome biogenesis and function of assembly factors. Her early research laid the foundation for significant advancements in understanding cellular machinery and gene expression. Following postdoctoral work at Karolinska institute, she joined the Broad institute of MIT and Harvard as a research scientist, where she leads techonology development for single-cell and spatial genomics at the Klarman cell observatory (KCO). 

Her work has significantly advanced our knowledge of cellular heterogeneity in human tissues, particularly concerning health and disease. Notably, she co-authored a seminal study on single-cell transcriptome profiling of human pancreatic islets, providing unprecedented insights into type 2 diabetes. Since joining the Broad institute, Åsa directs technology development at KCO, where she leads the spatial biology core facility. Her research contributions have garnered widespread recognition, with publications appearing in leading journals such as Nature, Cell metabolism, and NAR. 

Segerstolpe's extensive expertise in method and technology development makes her an exceptional fit for the role of Chief Operating Officer (COO) at Daice Labs. Her proficiency in developing cutting-edge techniques and managing complex research projects aligns perfectly with Daice Labs' mission to innovate in the fields of AI and contextual ecosystems. She brings a unique blend of scientific acumen and operational leadership, and her experience in single-cell and spatial biology equips her to oversee the development of advanced AI models that mimic biological processes—an area central to Daice Labs' focus on context-aware evolution and adaptability. Her ability to translate intricate data into actionable insights is invaluable for driving the company's initiatives.